Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Wim Quint"'
Autor:
Syed Rakin Ahmed, Brian Befano, Andreanne Lemay, Didem Egemen, Ana Cecilia Rodriguez, Sandeep Angara, Kanan Desai, Jose Jeronimo, Sameer Antani, Nicole Campos, Federica Inturrisi, Rebecca Perkins, Aimee Kreimer, Nicolas Wentzensen, Rolando Herrero, Marta del Pino, Wim Quint, Silvia de Sanjose, Mark Schiffman, Jayashree Kalpathy-Cramer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening involves detecting and treating
Externí odkaz:
https://doaj.org/article/5b8bb423fd0943a49499624df87224c8
Autor:
Hannah Dekker, MD, DDS, Rolf J. Bun, MD, DDS, Doriene C. Mulder, MD, DDS, Nelly Breeuwsma, MD, Jasper I. van der Rhee, MD, PhD, Núria Guimerà, MSc, PhD, Wim Quint, MSc, PhD, Maarten H. Vermeer, MD, PhD, Jan N. Bouwes Bavinck, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 6, Iss 9, Pp 822-825 (2020)
Externí odkaz:
https://doaj.org/article/5855bebf6efe45288ee5c7d32665add6
Autor:
Maria Alejo, Laia Alemany, Omar Clavero, Beatriz Quiros, Susana Vighi, Muhieddine Seoud, Chou Cheng-Yang, Suzanne M. Garland, Nuria Juanpere, Josep Lloreta, Sara Tous, Jo Ellen Klaustermeier, Wim Quint, F. Xavier Bosch, Silvia de Sanjosé, Belen Lloveras
Publikováno v:
Papillomavirus Research, Vol 5, Iss , Pp 134-142 (2018)
Aims: Neuroendocrine tumors (NET) of the cervix are rare tumors with a very aggressive course. The human papillomavirus (HPV) has been linked to its etiology. The objective of this study is to describe HPV prevalence and genotype distribution of NET.
Externí odkaz:
https://doaj.org/article/b44da9e0f82d42febbb0b4618c6e3414
Autor:
Elske Marra, Matthijs L. Siegenbeek van Heukelom, Annemiek Leeman, Tim Waterboer, Chris J.L.M. Meijer, Peter J.F. Snijders, Audrey J. King, Irina Cairo, Arne van Eeden, Wilma Brokking, Pascal van der Weele, Wim Quint, Jan M. Prins, Henry J.C. de Vries, Maarten F. Schim van der Loeff
Publikováno v:
Papillomavirus Research, Vol 5, Iss , Pp S9- (2018)
Background: Our objective was to identify virological and serological predictors of anal high-grade squamous intraepithelial lesions (HSIL) in HIV-positive men-who-have-sex-with-men (MSM). Methods: HIV-positive MSM were recruited from a longitudinal
Externí odkaz:
https://doaj.org/article/f02071b2ba7a4fd7acf02b44abafb555
Autor:
Annemiek Leeman, David Jenkins, Elske Marra, Edyta Pirog, Miekel van de Sandt, Maarten Schim van der Loeff, John Doorbar, Folkert van Kemenade, Chris Meijer, Wim Quint
Publikováno v:
Papillomavirus Research, Vol 5, Iss , Pp S8- (2018)
Background: Immunohistochemical (IHC) biomarkers enable standardised, reproducible grading of anal intraepithelial neoplasia (AIN) based on progression of HPV infection from transient productive infection to complete neoplastic transformation. We inv
Externí odkaz:
https://doaj.org/article/bb972ebeb522413ebc1495318abb9856
Autor:
Shih-Wen Lin, Arpita Ghosh, Carolina Porras, Sarah C Markt, Ana Cecilia Rodriguez, Mark Schiffman, Sholom Wacholder, Troy J Kemp, Ligia A Pinto, Paula Gonzalez, Nicolas Wentzensen, Mark T Esser, Katie Matys, Ariane Meuree, Wim Quint, Leen-Jan van Doorn, Rolando Herrero, Allan Hildesheim, Mahboobeh Safaeian, Costa Rican Vaccine Trial Group
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53067 (2013)
Several serological assays have been developed to detect antibodies elicited against infections with oncogenic human papillomavirus (HPV) type 16. The association between antibody levels measured by various assays and subsequent HPV infection risk ma
Externí odkaz:
https://doaj.org/article/e8ac17a43a5d443080e7004b849bb09c
Autor:
Rolando Herrero, Wim Quint, Allan Hildesheim, Paula Gonzalez, Linda Struijk, Hormuzd A Katki, Carolina Porras, Mark Schiffman, Ana Cecilia Rodriguez, Diane Solomon, Silvia Jimenez, John T Schiller, Douglas R Lowy, Leen-Jan van Doorn, Sholom Wacholder, Aimée R Kreimer, CVT Vaccine Group
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68329 (2013)
Human papillomavirus (HPV) infection, particularly with type 16, causes a growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in developed countries. In a double-blind controlled trial conducted to investigate vaccine eff
Externí odkaz:
https://doaj.org/article/b6ef4f8f370f4dc098731085ecca808c
Autor:
Heather Griffin, Zhonglin Wu, Rebecca Marnane, Vincent Dewar, Anco Molijn, Wim Quint, Christine Van Hoof, Frank Struyf, Brigitte Colau, David Jenkins, John Doorbar
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e49974 (2012)
High-risk human papillomavirus (HPV) infections are the cause of nearly all cases of cervical cancer. Although the detection of HPV DNA has proved useful in cervical diagnosis, it does not necessarily predict disease presence or severity, and cannot
Externí odkaz:
https://doaj.org/article/1e1623690b7943f384e7754dffd52773
Autor:
Jaimie Z Shing, Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N Sampson, John Schussler, John T Schiller, Douglas R Lowy, Mónica S Sierra, Loretto Carvajal, Aimée R Kreimer, Bernal Cortés, Paula González, Silvia E. Jiménez, Ana Cecilia Rodríguez, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark Sherman, Sholom Wacholder, Ligia A. Pinto, Troy J. Kemp, Mary K. Sidawy, Wim Quint, Leen-Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler
Publikováno v:
Lancet Oncol
In women vaccinated against human papillomavirus (HPV), reductions in cervical disease and related procedures results in more women having intact transformation zones, potentially increasing the risk of cervical lesions caused by non-vaccine-preventa
Autor:
Ligia A. Pinto, Allan Hildesheim, Leen-Jan van Doorn, Wim Quint, Gloriana Shelton, Troy Kemp, Rolando Herrero, Ana C. Rodriguez, Mark Schiffman, Sholom Wacholder, Douglas R. Lowy, Paula Gonzalez, John T. Schiller, Aimee Kreimer, Yuanji Pan, Carolina Porras, Mahboobeh Safaeian
The Costa Rica HPV16/18 Vaccine Trial (CVT) showed that four-year vaccine efficacy against 12-month HPV16/18 persistent infection was similarly high among women who received one, two, or the recommended three doses of the bivalent HPV16/18 L1 virus-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af7092ee4d86245d1f513994d6d6976
https://doi.org/10.1158/1940-6207.c.6544847
https://doi.org/10.1158/1940-6207.c.6544847